(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202203 | 202103 | % Var | 202203 | 202103 | % Var | 202203 | 202103 | % Var | |
| Sales | 13776.60 | 13987.40 | -1.51 | 47070.40 | 47687.20 | -1.29 | 47070.40 | 47687.20 | -1.29 |
| Other Income | 22.90 | 57.20 | -59.97 | 215.50 | 273.20 | -21.12 | 215.50 | 273.20 | -21.12 |
| PBIDT | 3752.00 | 4681.70 | -19.86 | 13067.50 | 15371.90 | -14.99 | 13067.50 | 15371.90 | -14.99 |
| Interest | 292.90 | 210.60 | 39.08 | 958.60 | 659.20 | 45.42 | 958.60 | 659.20 | 45.42 |
| PBDT | 3459.10 | 4471.10 | -22.63 | 12108.90 | 14712.70 | -17.70 | 12108.90 | 14712.70 | -17.70 |
| Depreciation | 609.40 | 507.30 | 20.13 | 2354.80 | 1966.40 | 19.75 | 2354.80 | 1966.40 | 19.75 |
| PBT | 2849.70 | 3963.80 | -28.11 | 9754.10 | 12746.30 | -23.48 | 9754.10 | 12746.30 | -23.48 |
| TAX | 637.50 | 1036.00 | -38.47 | 2253.20 | 3185.20 | -29.26 | 2253.20 | 3185.20 | -29.26 |
| Deferred Tax | -127.00 | -77.40 | 64.08 | -61.00 | -164.60 | -62.94 | -61.00 | -164.60 | -62.94 |
| PAT | 2212.20 | 2927.80 | -24.44 | 7500.90 | 9561.10 | -21.55 | 7500.90 | 9561.10 | -21.55 |
| Equity | 1074.70 | 1073.20 | 0.14 | 1074.70 | 1073.20 | 0.14 | 1074.70 | 1073.20 | 0.14 |
| PBIDTM(%) | 27.23 | 33.47 | -18.63 | 27.76 | 32.23 | -13.88 | 27.76 | 32.23 | -13.88 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1820.75 |
| Dr. Reddys Lab | 1270.95 |
| Cipla | 1333.55 |
| Zydus Lifesciences | 911.85 |
| Lupin | 2343.40 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: